[{"data": {"name": "First PARP Inhibitor Approved for Breast Cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://cancerdiscovery.aacrjournals.org/content/candisc/8/3/256.3.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Association for Cancer Research (AACR)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1158/2159-8290.cd-nb2018-008", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCcrdkJnNiZu7-CTj6HSNiTAfDK-CDWt43E6zRDRr-CRccY55dV8M1E", "propertyID": "ISCC"}], "datePublished": "2018-01-30"}, "schema": "schema.org", "mediatype": "application/ld+json"}]